The Venture Codex Logo

The Venture Codex

Furthr VC

Guinness Enterprise Centre, Taylors Lane, The Liberties, Dublin, Dublin 8, D08 W3Y8, Ireland

Overview

We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back. We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth. In addition to providing institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.

Total investments
13
Lead investments
6
Investments · 12mo
2
Active investors
2

Sector focus

  • B2B
  • Medical Device
  • Software
Visit website

Investment portfolio

  • WrxFlo

    Participated · Equity · Jul 2026

    Founded in 2019 by former Dell manufacturing executives Tim Crowe, Ken Sheehan and Jennifer Kelly, WrxFlo builds an AI-powered digital operations platform for manufacturers and logistics operators. The platform aims to replace spreadsheets and disconnected legacy systems with a single SaaS solution that connects data, applies AI and offers actionable insights. WrxFlo serves customers across Ireland, the UK, Germany, China and the United States and has more than doubled its annual recurring revenue ahead of the latest raise. The company reports customers have achieved up to 40% reductions in operational costs and productivity improvements of around 25% on production lines. WrxFlo currently employs about 60 people and plans to expand headcount to 200 by 2028 while using new funding to accelerate UK and US expansion and further develop its platform.

  • Neurobell

    Participated · Equity · Jun 2026

    NeuroBell develops LUNA, a battery-powered, WiFi-connected neonatal electroencephalogram (EEG) system that provides bedside, clinical-grade brain monitoring. LUNA features an eight-channel EEG amplifier, 10-20 EEG electrode placement for neonates, a two-button setup to begin recording, and continuous impedance checks. The system offers automated neonatal seizure detection to support quicker identification of seizures and decision-making by NICU staff. NeuroBell says LUNA enables quick setup and recording for NICU teams regardless of size or location and supports continuous monitoring at the bedside. The company is based in Cork, Ireland, and is anticipating FDA clearance in the coming months. NeuroBell raised $5.5 million in a financing led by Elkstone, with participation from Parkview Health and existing investors to support clinical deployment and U.S. market entry.

  • Trustap

    Participated · Series A · Jul 2024

    Trustap started as a Liverpool ticket escrow business and is now a Cork-based fintech focused on trust and escrow solutions for marketplaces and ecommerce. The company is positioning itself as a trust layer for AI shopping agents by building a product to make listings machine-readable and transactable by autonomous agents. Trustap raised $10M in a round led by Aperture Capital with participation from TX Ventures to fund that product launch. The announcement frames the financing as enabling product development and commercialization for agent-driven marketplace transactions. No valuation or prior round details were disclosed in the report.

  • SymPhysis Medical

    Participated · Equity · Dec 2023

    SymPhysis Medical is building Releaze, a port-style drainage system that combines a safety-valve catheter with a compact external hub, allowing patients and carers to relieve malignant pleural effusion at home instead of enduring repeated hospital procedures. The condition, which causes painful fluid build-up in the chest, affects more than 150,000 people annually in the United States, and Releaze aims to improve comfort and reduce hospital visits for these patients. Headquartered in Galway, the company has worked closely with Irish clinicians, nurses, patients and carers to design and refine the device. With the new U.S. grant, SymPhysis Medical will open its first American base in Rhode Island, advance testing and move toward its initial FDA regulatory clearance. The firm also plans to build partnerships across New England’s life-sciences cluster while continuing to expand engineering and operations in Ireland. To date, the company has raised over €4 million from Irish and European investors and health-innovation programmes, adding to the latest U.S. public-sector funding. These combined resources provide the runway to progress Releaze toward early international commercialisation.

  • GREYSCOUT

    Participated · Seed · Nov 2023

    GreyScout is a SaaS platform for online brand protection that safeguards brands from grey market activity and counterfeit selling. The platform programmatically monitors ecommerce channels to proactively identify intellectual property infringements and grey market vendors. It supports detection, verification, and enforcement workflows to help brands remediate violations. The company is trusted by clients including Nestle, Bayer, Netgear, Mayborn, and Dorel Maxi‑Cosi. In November 2023 GreyScout raised €3.5M in a seed round, bringing total capital raised to €4.5M, and plans to use the funding to expand its product, engineering, and platform capabilities. Founded in 2020 and based in Dublin, Ireland, GreyScout aims to meet growing demand for automated brand protection across ecommerce channels.

Team